303 related articles for article (PubMed ID: 22466463)
1. Pattern dystrophy with high intrafamilial variability associated with Y141C mutation in the peripherin/RDS gene and successful treatment of subfoveal CNV related to multifocal pattern type with anti-VEGF (ranibizumab) intravitreal injections.
Vaclavik V; Tran HV; Gaillard MC; Schorderet DF; Munier FL
Retina; 2012 Oct; 32(9):1942-9. PubMed ID: 22466463
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.
Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D
Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013
[TBL] [Abstract][Full Text] [Related]
3. Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin/RDS gene.
Michaelides M; Holder GE; Bradshaw K; Hunt DM; Moore AT
Ophthalmology; 2005 Sep; 112(9):1592-8. PubMed ID: 16019073
[TBL] [Abstract][Full Text] [Related]
4. Treatment and longitudinal follow-up of CNV associated with pattern dystrophy with novel
Xu J; Li K; Zheng B; Dai H
Ophthalmic Genet; 2021 Dec; 42(6):768-772. PubMed ID: 34486473
[TBL] [Abstract][Full Text] [Related]
5. Central areolar choroidal dystrophy.
Boon CJ; Klevering BJ; Cremers FP; Zonneveld-Vrieling MN; Theelen T; Den Hollander AI; Hoyng CB
Ophthalmology; 2009 Apr; 116(4):771-82, 782.e1. PubMed ID: 19243827
[TBL] [Abstract][Full Text] [Related]
6. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
7. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications.
Iannaccone A; Kerr NC; Kinnick TR; Calzada JI; Stone EM
Arch Ophthalmol; 2011 Feb; 129(2):211-7. PubMed ID: 21320969
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the peripherin/RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus.
Boon CJ; van Schooneveld MJ; den Hollander AI; van Lith-Verhoeven JJ; Zonneveld-Vrieling MN; Theelen T; Cremers FP; Hoyng CB; Klevering BJ
Br J Ophthalmol; 2007 Nov; 91(11):1504-11. PubMed ID: 17504850
[TBL] [Abstract][Full Text] [Related]
9. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
10. Clinical findings in a multigeneration family with autosomal dominant central areolar choroidal dystrophy associated with an Arg195Leu mutation in the peripherin/RDS gene.
Keilhauer CN; Meigen T; Weber BH
Arch Ophthalmol; 2006 Jul; 124(7):1020-7. PubMed ID: 16832026
[TBL] [Abstract][Full Text] [Related]
11. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M
Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab and bevacizumab therapy for choroidal neovascularization in age-related macular degeneration with extensive pre-existing geographic atrophy.
Amaro MH; Roller AB
Arq Bras Oftalmol; 2012; 75(4):273-6. PubMed ID: 23258660
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum.
Battaglia Parodi M; Romano F; Marchese A; Arrigo A; Llorenç V; Cicinelli MV; Bandello F; Adán A
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):273-278. PubMed ID: 30470876
[TBL] [Abstract][Full Text] [Related]
15. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes.
Gliem M; Müller PL; Mangold E; Holz FG; Bolz HJ; Stöhr H; Weber BH; Charbel Issa P
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2664-76. PubMed ID: 25766588
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
17. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
18. Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization.
Fuerst NM; Serrano L; Han G; Morgan JI; Maguire AM; Leroy BP; Kim BJ; Aleman TS
Ophthalmic Genet; 2016 Dec; 37(4):445-452. PubMed ID: 27028354
[TBL] [Abstract][Full Text] [Related]
19. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
[TBL] [Abstract][Full Text] [Related]
20. Late-onset autosomal dominant macular dystrophy with choroidal neovascularization and nonexudative maculopathy associated with mutation in the RDS gene.
Khani SC; Karoukis AJ; Young JE; Ambasudhan R; Burch T; Stockton R; Lewis RA; Sullivan LS; Daiger SP; Reichel E; Ayyagari R
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3570-7. PubMed ID: 12882809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
